Global Advanced Drug Delivery Market Research Report 2019 (Includes Business Impact of COVID-19)

                                          
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Advanced Drug Delivery market.

Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Advanced Drug Delivery market."
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Drug delivery is often approached via a drugs chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration, the latter sometimes even being considered part of the definition.
The Global Advanced Drug Delivery Market is poised to grow at a CAGR of around 7.8% over the next decade to reach approximately $340 billion by 2025. Some of the prominent trends that the market is witnessing include growing focus on unmet medical requirements, increasing demand for generic drugs and biosimilars, rising familiarities of chronic diseases and recent technological developments of advanced drug delivery.
Based on technology, the market is categorized into polymeric drug delivery, implants & IUDs, sustained release, targeted drug delivery and prodrugs. By polymeric drug delivery, the market is further divided into nebulizers, metered dose inhalers and dry powder inhalers. 
By end user, the market is segregated into hospitals, diagnostic centers, ambulatory surgical centers/clinics, home care settings and other end users.

The global Advanced Drug Delivery market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Advanced Drug Delivery volume and value at global level, regional level and company level. From a global perspective, this report represents overall Advanced Drug Delivery market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
    Merck & Co
    Antares Pharma
    F. Hoffmann-La Roche
    Novartis
    Bayer
    Sanofi
    Glaxosmithkline
    3M
    Pfizer
    Johnson & Johnson
    Abbott Laboratories
    Allergan
    Baxter International
    Mylan Pharmaceutical
    Roche Holding

Segment by Regions
    North America
    Europe
    China
    Japan

Segment by Type
    Polymeric Drug Delivery
    Implants & IUDs
    Sustained Release
    Targeted Drug Delivery
    Prodrugs

Segment by Application
    Hospitals
    Diagnostic Centers
    Ambulatory Surgical Centers/Clinics
    Home Care Settings
    Other End Users